Clinical Drug Experience Knowledgebase

Anemia (Phase 2)

Anemia, Diamond-Blackfan (Phase 2)

Bone Marrow Cells (Phase 2)

Bone Marrow Failure Disorders (Phase 2)

Burkitt Lymphoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Graft vs Host Disease (Phase 2)

Hematologic Neoplasms (Phase 2)

Hemoglobinopathies (Phase 2)

Hemoglobinuria, Paroxysmal (Phase 2)

Hodgkin Disease (Phase 2)

Leukemia (Phase 2)

Leukemia, Biphenotypic, Acute (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Leukemia, Prolymphocytic (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 3)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Melanoma (Phase 3)

Metabolism, Inborn Errors (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 2)

Neoplasm, Residual (Phase 2)

Neoplasms (Phase 2)

Nijmegen Breakage Syndrome (Phase 2)

Ovarian Neoplasms (Phase 3)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Primary Immunodeficiency Diseases (Phase 2)

Prostatic Neoplasms (Phase 2)

Sarcoma, Ewing (Phase 3)

Shwachman-Diamond Syndrome (Phase 2)

Transplantation, Homologous (Phase 2)